A new option for adults who have experienced stroke will now be available to further reduce future risk.
News|Articles|July 23, 2007
These treatments are not so nice to lice
This fall there are a host of new products to treat lice and there are many companies that are currently working on new treatments.
Advertisement
On the market
New treatments
For a free booklet on lice, visit The Lice Advisory Bureau's Web site at
The National Pediculosis Association urges parents to avoid dangerous pesticides and treatments that contain the chemical lindane. The NPA urges a holistic approach using The LiceMeister Comb. NPA developed the comb. For more information, visit
Finally, visit
Advertisement
Related to this article
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.
Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
Investigators believe triglyceride testing could improve viral sepsis risk more broadly based on study findings.
Nicholas Rebold, PharmD, MPH, BCIDP, AAHIVP, explains how education eases inpatient switches, and how the protocol cuts costs and simplifies workflow.
Mark Ey, RPh, from NCPA, joins to discuss the opportunities for independent pharmacies within the ACCESS to Pharmacy Care Program.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Asundexian, First FXIa Inhibitor for Stroke Prevention
2
The Outcome-Based Program That Could Reshape Pharmacists’ Roles
3
High Triglycerides Independently Linked with Severe COVID-19 Death
4
US Lost Over 3000 Pharmacies From 2022 to 2024, Mostly Chains
5